Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs NTR✓SelectedUSD · NTRGSK vs NTR performance historyLatest closeAs of-1.34%11/18
Stock and ETF performance explorer

GSK vs NTR

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+42.8%
NTR return
+13.2%
Excess return
+29.6%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioNTRExcessAlpha
1D-1.3%-4.8%+3.4%-1.0%
7D-3.1%-8.0%+4.9%-2.6%
30D-0.9%-5.1%+4.2%-0.5%
3M-4.2%-4.3%+0.1%-3.9%
6M-1.6%-6.4%+4.8%-1.3%
YTD+2.6%+9.4%-6.8%+1.2%
1Y+6.2%+17.8%-11.6%+4.1%
3Y+55.0%+28.6%+26.4%+49.1%
5Y+42.8%+11.0%+31.8%+31.8%
All+42.8%+13.2%+29.6%+31.8%

Cumulative growth

Daily Returns

Daily percentage return beside NTR.

Daily Out/Under-Performance

Portfolio return minus NTR return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × NTR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded NTR wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling